Contract Research Focus Novoprotein is a dedicated contract research biotech specializing in recombinant protein services, offering end-to-end capabilities from expression to crystallization. This presents opportunities to upsell extended service packages, custom enzyme and cytokine catalog expansion, and long-term collaborations with pharmaceutical and research clients seeking reliable CRO support.

Global Client Base With long-term clients spanning major pharma and world-class institutes worldwide and a history of over 1,000 projects at an 85% success rate, there is a strong foundation for expanded workstreams, multi-project programs, and preferred partner arrangements that can be leveraged for new seat licenses, project-based pricing, and regional expansions.

Diverse Expression Platforms Having four gram-scale expression systems (E. coli, yeast, baculovirus/insect cells, and mammalian) enables flexible project scoping and rapid prototyping for customers with varied protein production needs, suggesting cross-sell of platform-specific optimization, scale-up services, and tailor-made QC workflows to reduce time-to-result.

Quality and Confidentiality Strict QC standards and confidentiality protocols position Novoprotein as a trustworthy partner for sensitive blockbuster programs and confidential programs, offering opportunities to reinforce value propositions around IP protection, data security, and compliance-driven engagements with large biopharma accounts.

Growth and Enablement Revenue range indicates a scalable mid-size CRO with room to grow through expanded catalog (over 800 enzymes and cytokines) and additional services, suggesting potential sales plays around bundled protein service offerings, maintenance of existing client relationships, and entry into adjacent markets such as antibody production and protein modification.